SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-246169
Filing Date
2021-08-13
Accepted
2021-08-13 16:42:19
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d213609d10q.htm   iXBRL 10-Q 1420060
2 EX-31.1 d213609dex311.htm EX-31.1 6297
3 EX-31.2 d213609dex312.htm EX-31.2 7721
4 EX-32.1 d213609dex321.htm EX-32.1 6186
  Complete submission text file 0001193125-21-246169.txt   5346838

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20210630.xsd EX-101.SCH 37256
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20210630_cal.xml EX-101.CAL 34858
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20210630_def.xml EX-101.DEF 135704
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20210630_lab.xml EX-101.LAB 326781
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20210630_pre.xml EX-101.PRE 252024
10 EXTRACTED XBRL INSTANCE DOCUMENT d213609d10q_htm.xml XML 810789
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 211172907
SIC: 2834 Pharmaceutical Preparations